Elypta

Description

Elypta develops standardized, scalable assays that quantify glycosaminoglycan (GAG) profiles in human biofluids to enable longitudinal cancer risk–stratification and support research use of GAGome kits.

Elypta is located in the Stockholm ecosystem.

Related

• CellplyCellply provides an automated single-cell analysis platform that profiles immune and cancer cells to support discovery and development of…
• PixelgenPixelgen develops DNA‑based Proximity Network Assay technology that maps nanoscale spatial organization of cell‑surface proteins in single…
• ElektaElekta develops radiotherapy, brachytherapy and imaging systems for precision radiation medicine used by hospitals and cancer centres to…
• Devyser DiagnosticsDevyser Diagnostics develops DNA test kits and integrated software for laboratory DNA diagnostics, helping labs run genetic testing…
• BioportoBioporto provides clinicians with NGAL biomarker tools for acute kidney injury risk assessment and diagnosis, and supplies NGAL ELISA kits…
• AcytronixAcytronix provides PMED, a portable microstructured electrochemical device that rapidly isolates extracellular vesicles from biofluids…
• AnaCardioAnaCardio develops novel inotropic drugs that act via the ghrelin signalling pathway to increase cardiomyocyte contractility and cardiac…
• 3H Biomedical3H Biomedical supplies primary human and animal cell-based products, RNA, DNA, assays and culture media for life science research, drug…
• UniogenUniogen provides biotech CDMO services, develops custom assays and laboratory instruments, and creates technologies—such as glycovariant…